Concepedia

Sarah R. Helman

SR

Statistics

Publications

5

Citations

859

H-Index

5

Active since

2015

Affiliations

National Cancer Institute(Current)

Fred Hutch Cancer Center

Memorial Sloan Kettering Cancer Center

Johns Hopkins University

Frederick National Laboratory for Cancer Research

Sarah R. Helman is an author at National Cancer Institute specializing in life sciences, oncology, and immunotherapy.

ORCID

Publications per year

2015–2019

5

Publications

5

Landscape of immunogenic tumor antigens in successful immunotherapy of virally induced epithelial cancer

Sanja Stevanović, Anna Pasetto, Sarah R. Helman et al. · Science · 2017 · 384 citations

, , +17

A Phase II Study of Tumor-infiltrating Lymphocyte Therapy for Human Papillomavirus–associated Epithelial Cancers

Sanja Stevanović, Sarah R. Helman, John R. Wunderlich et al. · Clinical Cancer Research · 2018 · 293 citations · Full text

, , +15

Systematic Identification of Cyclic-di-GMP Binding Proteins in Vibrio cholerae Reveals a Novel Class of Cyclic-di-GMP-Binding ATPases Associated with Type II Secretion Systems

Kevin Roelofs, Christopher J. Jones, Sarah R. Helman et al. · PLoS Pathogens · 2015 · 132 citations · Full text

, , +15

Cancer targeting by TCR gene-engineered T cells directed against Kita-Kyushu Lung Cancer Antigen-1

Bridget C. Marcinkowski, Sanja Stevanović, Sarah R. Helman et al. · Journal for ImmunoTherapy of Cancer · 2019 · 39 citations · Full text

, , +15

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

Andreas Lundqvist, Vincent van Hoef, Xiaonan Zhang et al. · Journal for ImmunoTherapy of Cancer · 2016 · 11 citations · Full text

, , +13

1–5 of 5